RxDoctor Payments Data

John Borkowski, MD

Orthopaedic Surgery · Corpus Christi, TXNPI 1316959661

Payments from drug & device makers

$6,695in general payments, 2019–2025

Across 269 payments — averaging $24.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$2K
  • Biotronik NRO, Inc.$1K
  • Nevro Corp.$917
  • Boston Scientific$668
  • Medtronic$516
  • Globus Medical$455
  • plus $1K from 15 others

What the payments were for

  • Food & beverage$6,64499%
  • Other$511%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,695 in reported general payments places this provider in the 55th percentile of 1,337 orthopaedic surgery providers in Texas.

See all orthopaedic surgery providers in Texas

Medicare billing

Part B allowed, 2024
$262,694
Medicare patients
491
Services billed
3,624

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
ProliaDenosumab20$35,314
Pregabalin829$13,455
Celecoxib1,152$13,369
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen438$10,013
Gabapentin520$6,453
Diclofenac Sodium379$4,519
Acetaminophen-CodeineAcetaminophen With Codeine276$4,465
Tramadol Hcl581$4,272
Cyclobenzaprine Hcl129$1,438
Carisoprodol67$1,433
Tizanidine Hcl57$883
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen49$744
Cephalexin67$737
Meloxicam216$473
Mupirocin30$328

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AmgenProlia$101$35,31420 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 1,337 orthopaedic surgery providers in Texas.

Other orthopaedic surgery in Corpus Christi

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →